| Typicality: | 0.249 |
| Saliency: | 0.149 |
| by the time | 2 | temporal |
| therapy → receive → fda approval | 4 |
| therapy → gain → fda approval | 3 |
| negative | neutral | positive |
| 0.202 | 0.497 | 0.301 |
| Raw frequency | 7 |
| Normalized frequency | 0.149 |
| Modifier score | 0.300 |
| Perplexity | 345.136 |